• October 18, 2011
      NEW YORK, N.Y., October 18 - Pfizer Animal Health and The Resource Foundation announced today the expansion of a comprehensive education and training program to increase the capacity, productivity and quality of life of rural farmers in eight Latin American countries.  Plans call for tailoring the program to the needs of rural communities in India.  The agreement was guided by results of a decade-long collaboration also announced today.  Pfizer Animal Health and themore...
  • October 13, 2011
    MADISON, N.J.--Five livestock veterinarians and about 20 of their client farms in four states volunteered to be filmed for a new reality series, to give consumers a personal and up-close view of responsible livestock farming in the U.S. The series, “Veterinarians on Call,” captures the pride and responsibility of veterinarians in their day-to-day work on U.S. farms and ranches, working with their client livestock farmers and othermore...
  • September 8, 2011
    MADISON, N.J., & HUINAN, China--Pfizer Animal Health, a business unit of Pfizer Inc. (NYSE: PFE), and Jilin Guoyuan Animal Health Company, Ltd., an innovator in animal health vaccines based in Huinan, today announced an agreement to jointly develop, manufacture and distribute animal health vaccines in China. The new joint venture, Jilin Pfizer Guoyuan Animal Health Co., Ltd., will bolster the capabilities of both companies to offer amore...
  • July 7, 2011
    NEW YORK--Pfizer Inc. (NYSE: PFE) today announced that it is exploring strategic alternatives for its Animal Health and Nutrition businesses based on its recent business portfolio review to determine the optimal mix of businesses for maximizing shareholder value. The company is considering options that may include, among others, a full or partial separation of each of these businesses from Pfizer through a spin-off, sale or other transaction.more...
  • June 22, 2011
    Brussels--Click below to read the IFAH Press Release Alejandro Bernal Elected Chairman of International Federation for Animal Health - Europe more...
  • June 8, 2011
    Madison, N.J.--Pfizer Inc.’s Alpharma LLC subsidiary has decided to suspend sales in the United States of 3-Nitroâ (Roxarsone), a feed medicine used primarily in poultry production. Pfizer is taking this action in response to a request by the U.S. Food and Drug Administration (FDA) based on a recent study by the Agency. This study used a new method of testing for very low levels of inorganic arsenic in poultry tissue. The study found that themore...
  • May 11, 2011
    MADISON, NJ--Pfizer Animal Health and American Humane Association today announced a partnership to conduct a study on the impact of animal-assisted therapy on pediatric oncology patients, as well as on their parents, caregivers, siblings, and other close family members. The partnership — which includes a $282,000 grant from Pfizer and the Pfizer Foundation — exemplifies the strategic goal of both organizations to better quantify inmore...
  • March 7, 2011
    Durham, NC--Pfizer Poultry Health has introduced a broader, diversified portfolio of products and services with the acquisition of Alpharma LLC as part of Pfizer’s acquisition of King Pharmaceuticals. With the acquisition of Alpharma, Pfizer Poultry Health now offers a wider portfolio of products and services than any other global poultry healthcare provider. “The integration expands Pfizer Poultry Health’s product portfolio andmore...
  • January 28, 2011
    RALEIGH, N.C.--Visitors to the VIV Asia 2011 exhibition in Bangkok in March will be able to see the new, expanded portfolio from Pfizer Poultry Health, including one of its fully automated in ovo injection devices. Though the company has a wide range of health solutions covering the major poultry production diseases, its focus is on the individual farm, says Hari Yethirajyam Prasad, Asia-Pacific Regional Marketing Directormore...
  • January 26, 2011
    RALEIGH, N.C.--Pfizer Poultry Health is offering U.S. poultry producers a new option to optimize protection against one of the poultry industry’s most costly diseases, coccidiosis. Inovocox® EM1 is specially formulated to fight coccidiosis - the intestinal parasitic disease with an annual estimated global economic impact exceeding $3 billion. The new formulation accompanies the vaccine Inovocox® - launched in early 2009more...